Multimodal Assessment of Protein Functional Deficiency Supports Pathogenicity of BRCA1 p.V1688del

Arcangela De Nicolo(Riga Stradiņš University), Judy E. Garber(Dana-Farber Cancer Institute)

Cancer Research

August 25, 2009

10.1158/0008-5472.can-09-1440

Cited by 15

Related Papers

Mutational Processes Molding the Genomes of 21 Breast Cancers

|Cell|2012|2k

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

|The Lancet|2010|1.6k

Molecular Definition of Breast Tumor Heterogeneity

|Cancer Cell|2007|1.4k

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

|Annals of Oncology|2017|1.3k

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer

|Clinical Cancer Research|2016|1.2k